Avicanna CEO Aras Azadian joined Steve Darling from Proactive Investors in our Toronto Studio to discuss their BioPharma company that is using cannabinoids in its products. With its vertical integration, Avicanna has developed a derma-cosmetic line, a phytotherapeutic line, and is in various stages of clinical testing for pharmaceutical development
Azadian telling Proactive about their recent fundraise and how they are taking a big step forward by going public.
Azadian telling Proactive about their recent fundraise and how they are taking a big step forward by going public.
